4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-20-008104
Corporate Executive VP & CFO sold 4,188 shares at an average $162.26 ($679,535)
- Corporate Executive VP & CFO acquired 4,188 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith David Ross Corporate Executive VP & CFO | 2020-02-26 | Option exercise | +4,188 | $73.70 | $308,656 | 24,663 | D |
| Smith David Ross Corporate Executive VP & CFO | 2020-02-26 | Sale | −868 | $160.45 | $139,271 | 23,795 | D |
| Smith David Ross Corporate Executive VP & CFO | 2020-02-26 | Sale | −898 | $161.58 | $145,095 | 22,897 | D |
| Smith David Ross Corporate Executive VP & CFO | 2020-02-26 | Sale | −1,027 | $162.27 | $166,654 | 21,870 | D |
| Smith David Ross Corporate Executive VP & CFO | 2020-02-26 | Sale | −657 | $163.38 | $107,339 | 21,213 | D |
| Smith David Ross Corporate Executive VP & CFO | 2020-02-26 | Sale | −738 | $164.19 | $121,176 | 20,475 | D |
| Derivatives | |||||||
| Smith David Ross Corporate Executive VP & CFO | 2020-02-26 | Option exercise · Stock Options (Right to Buy) | −4,188 | 0 | D | ||
| Open-market sales · 4,188 sh · avg $162.26 · $679,535 | |||||||
Loading xslF345X03/form4.xml…